 Angiotensin enzyme inhibitors Present future angiotensin enzyme ACE agents diuretic agents beta-adrenergic receptor-blocking agents calcium antagonists therapeutic options major consideration initial treatment hypertensive patients compounds potent pressor mechanism hypertensive disease ACE inhibitors generation potent octapeptide angiotensin II addition degradation potent vasodilator bradykinin Hemodynamically ACE inhibitors arterial pressure decreased total peripheral resistance unassociated reflex stimulation heart expansion intravascular volume arteriolar dilation accounting decreased vascular resistance target organ disease direct-acting smooth muscle vasodilators adrenergic inhibitors ACE inhibitors efferent afferent glomerular arterioles glomerular hydrostatic pressure renal filtration fraction renal blood flow glomerular filtration rate ACE-inhibiting compounds ventricular afterload hypertension diminish cardiac mass wall thicknesses mechanism actions autocrine/paracrine actions renopressor system effects cellular biologic events vascular smooth muscle cardiac myocyte plausible local renin-angiotensin systems ACE inhibitors new applications class pharmacological agents